2 unknown, 1 completed. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 2, Completed 1 |
| Phase 2 | 2 | Unknown 2 |
Follow Dystonic Disorders: new trials by email Literature Review of Dystonic Disorders trials Research Report on Dystonic Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Botulinum Toxin Type A for Foot Dystonia-associated Pain in Parkinson's Disease Botulinum toxin type A, Placebo - Dystonia Disorder, Parkinson Disease | Phase 2 / Phase 3 | Unknown | University of Calgary | 40 | 2021-01-12 | 2022-05-17 |
| Wumeiwan Jiawei Fang Use in Patients With Blepharospasm Wumeiwan Jiawei Fang, botulinum toxin A - Dry Eye Syndromes, Meige Syndrome | Phase 2 / Phase 3 | Unknown | China Academy of Chinese Medical Sciences | 80 | 2018-01-12 | 2022-11-17 |
| Meditoxin® Treatment in Patients With Cervical Dystonia Meditoxin, Placebo - Dystonia, Dystonic Disorder | Phase 3 | Completed | Medy-Tox | 66 | 2017-07-06 | 2019-03-27 |
Blepharospasm (1) · Dry Eye Syndromes (1) · Dystonia (1) · Meige Syndrome (1) · Parkinson Disease (1) · Spasm (1)
Central Nervous System Diseases (3) · Movement Disorders (3) · Nervous System Diseases (3) · Basal Ganglia Diseases (2) · Brain Diseases (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Dyskinesias (1) · Eye Diseases (1) · Eyelid Diseases (1) · Lacrimal Apparatus Diseases (1) · Neurodegenerative Diseases (1) · Neuromuscular Manifestations (1)
Botulinum Toxins, Type A (3) · Sodium Chloride (1)
China Academy of Chinese Medical Sciences (1) · Medy-Tox (1) · University of Calgary (1)
Canada (1) · China (1) · South Korea (1)